Langlois Sophia J. 4

4 · Keenova Therapeutics plc · Filed Jun 4, 2026

AI-generated summary of this filing

Updated Jun 4, 2026

Keenova Director Sophia Langlois Exercises RSUs; Shares Withheld

What Happened

Sophia J. Langlois, a director of Keenova Therapeutics plc, had restricted stock units (RSUs) settle on June 2, 2026. The filing reports 2,685 RSUs converted into ordinary shares (one share per RSU). Of the resulting shares, 1,289 were withheld to satisfy tax withholding obligations, and 2,197 RSUs were forfeited/disposed to the issuer pursuant to an agreement with the company. No cash purchase price or market value is reported for these transactions.

Key Details

Transaction date: June 2, 2026; Form 4 filed June 4, 2026 (appears timely).
Reported events/codes: M (exercise/conversion of derivative — RSU settlement) 2,685 shares; F (tax withholding) 1,289 shares; D (disposition to issuer) 2,197 shares. One entry shows the derivative conversion with $0.00 price.
Shares owned after the transactions: not specified in the provided filing.
Notable footnotes:
- F1: Each settled RSU converted to one ordinary share.
- F2: Tax-withheld share count was based on a percentage; no market value used because Keenova shares are not listed or quoted.
- F3/F5: The 2,197 RSUs were forfeited under an agreement in exchange for a payment from the issuer to help the reporting person satisfy certain tax obligations.
- F4: The RSUs were granted Aug 14, 2025 and vest on the earlier of the first anniversary of the grant or the issuer’s next annual general meeting.
Filing also serves as notice to the issuer under Part V of the Companies Act 2014 (per the filing’s remarks).

Context

These were RSU settlements and administrative dispositions (tax withholding and a negotiated forfeiture/payment), not open-market sales or purchases; such transactions often reflect routine vesting and tax handling rather than a buy/sell signal.
Because the company’s shares are not listed/quoted, no dollar values or market prices were reported in the filing.

Form 4

Period: 2026-06-02

Director

Transactions

Exercise/Conversion
Ordinary Shares
[F1]
2026-06-02+2,685→ 3,480 total
Tax Payment
Ordinary Shares
[F2]
2026-06-02−1,289→ 2,191 total
Disposition to Issuer
Restricted Stock Units
[F3][F5][F4]
2026-06-02−2,197→ 6,669 total
→ Ordinary Shares (2,197 underlying)
Exercise/Conversion
Restricted Stock Units
[F1][F4]
2026-06-02−2,685→ 3,984 total
→ Ordinary Shares (2,685 underlying)

Footnotes (5)

[F1]Each restricted stock unit (the "RSU") that was settled, was settled in ordinary shares of the Issuer at one share per RSU.
[F2]The number of ordinary shares withheld to satisfy tax withholding obligations arising out the vesting of RSUs is based on a percentage and did not take into account any market value as the Issuer's ordinary shares are not listed or quoted on a recognized trading market.
[F3]The Reporting Person entered into an agreement with the Issuer pursuant to which the Reporting Person forfeited the right to receive 2,197 RSUs that would otherwise have vested in exchange for a payment from the Issuer to facilitate the Reporting Person's ability to satisfy certain tax obligations related to the RSUs scheduled to vest.
[F4]The RSUs, which were granted on August 14, 2025, vest on the earlier of (i) the first anniversary of the grant date and (ii) the date of the Issuer's next annual general meeting of shareholders.
[F5]The number of RSUs forfeited is based on a percentage.

Signature

/s/ Mark Tyndall, Attorney-in-Fact|2026-06-04

1 file